HRT may triple breast cancer risk

Taking combined HRT over five years nearly triples the risk of breast cancer in postmenopausal women, a prospective study shows, leading researchers to posit that the relative risk has previously been underestimated.

Reassuringly, however, the increased risk of cancer associated with HRT disappears once therapy is discontinued.